Vaxart, Inc. (VXRT)

Every figure this model derived for VXRT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 601,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 63,976,000 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 116,691,000 AssetsCurrent 2026-06-30
current liabilities 73,108,000 LiabilitiesCurrent 2026-06-30
equity 82,371,000 StockholdersEquity 2026-06-30
ocf 33,982,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 243,064,000 Revenues 2026-06-30
sbc 6,506,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up VXRT on one particular measure came for.

RatioValue
cash operating margin21.44
current ratio1.6
current ratio reported1.6
deferred revenue growth-100.0
dilution pct13.97
fcf margin13.73
growth cv1.73
operating margin16.3
owner earnings margin11.06
revenue growth201.1
revenue growth per share164.21
roic170.12
rpo growth-100.0
rule of 40217.4
sbc pct revenue2.68

What to be careful about

What this model itself distrusts about VXRT's figures. Written by the derivation as it ran, not added afterwards.